![雙[三(羥甲基)氨基甲烷],CAS:6976-37-0](http://struc.chem960.com/strucimg/7000/ctzw0nzi34oyob9fnlmhiwee.png)
Lucigen 美國(guó)Lucigen公司，自1998年成立至今，一直致力于生命科學(xué)領(lǐng)域相關(guān)科研產(chǎn)品的研究與開(kāi)發(fā)，在分子生物學(xué)領(lǐng)域處于領(lǐng)導(dǎo)性地位。Lucigen公司主要開(kāi)發(fā)各類(lèi)用于基因克隆的試劑盒及相關(guān)產(chǎn)品，包括：CloneSmart®平端克隆試劑盒、BigEasy®線(xiàn)性克隆系統(tǒng)、pEZSeq™平端克隆試劑盒、ClonePlex™ AK文庫(kù)構(gòu)建試劑盒、DNA Terminator ®末端修復(fù)試劑盒、EconoTaq® DNA聚合酶及E.cloni感受態(tài)細(xì)胞等。Lucigen公司憑借其獨(dú)到的產(chǎn)品技術(shù)，過(guò)硬的產(chǎn)品質(zhì)量，良好的產(chǎn)品服務(wù)贏得了全球廣大用戶(hù)的信賴(lài)。
美國(guó)Lucigen公司主要開(kāi)發(fā)各類(lèi)用于基因克隆的試劑盒及相關(guān)產(chǎn)品，憑借其獨(dú)到的產(chǎn)品技術(shù)，過(guò)硬的產(chǎn)品質(zhì)量，良好的產(chǎn)品服務(wù)贏得了全球廣大用戶(hù)的信賴(lài)。
Lucigen Corporation is working to improve people’s lives by providing quality products and services to life science and healthcare professionals. Founded in Wisconsin in 1998, Lucigen offers products and services that enable life-science professionals to perform their research and testing more efficiently and effectively. The company has grown to manufacture and sell over 325 biomedical research products and services to customers worldwide, all under an ISO 13485 compliant quality system. Core competencies include enzyme evolution, protein expression, cloning, competent cells, next gen sequencing, and molecular diagnostics.
美國(guó)Lucigen公司主要開(kāi)發(fā)各類(lèi)用于基因克隆的試劑盒及相關(guān)產(chǎn)品，憑借其獨(dú)到的產(chǎn)品技術(shù)，過(guò)硬的產(chǎn)品質(zhì)量，良好的產(chǎn)品服務(wù)贏得了全球廣大用戶(hù)的信賴(lài)。
Lucigen Corporation is working to improve people’s lives by providing quality products and services to life science and healthcare professionals. Founded in Wisconsin in 1998, Lucigen offers products and services that enable life-science professionals to perform their research and testing more efficiently and effectively. The company has grown to manufacture and sell over 325 biomedical research products and services to customers worldwide, all under an ISO 13485 compliant quality system. Core competencies include enzyme evolution, protein expression, cloning, competent cells, next gen sequencing, and molecular diagnostics.
